Parabilis Medicines, Inc. [PBLS] - appoints Craig Tendler as Director
On August 22, 2026, Parabilis Medicines, Inc. appointed Craig Tendler as a Class II director, granting him a stock option to purchase 20,294 shares at an exercise price of $39.36 per share, along with an annual retainer of $40,000 for Board service and $7,500 for Science Technology Committee service.
Why this matters
Generating analysis…